phase readout

NCT07310134: Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ZX-8177 in Patients With Advanced Solid Tumors

RECRUITINGupdated 1mo ago

community read0 votes

Sponsor: Nanjing Zenshine Pharmaceuticals. Phase: PHASE1. Conditions: Advanced Solid Tumors

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 3m ago

Found something off?